BioMedical firm acquires wound device maker

Wednesday, February 4, 2015

LANGHORNE, Pa. – Alliqua BioMedical, a maker of wound care products, has agreed to acquire Eden Prairie-based Celleration for $30.4 million in stock and cash, according to an article in the Philadelphia Business Journal. Celleration is the manufacturer of MIST Therapy, an ultrasound system for treating acute and chronic wounds. Celleration had revenues of about $8.7 million in 2014. The deal will nearly double the size of Alliqua’s sales force, said CEO David Johnson in the article.